Source: Annual Congress 2010 - Novel markers of lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. de Torres, C. Casanova, V. Pinto Plata, N. Varo, P. Restituto, E. Cordova, R. Baz, A. Aguirre-Jaime, B. Celli (Pamplona, Tenerife, Spain; Boston, United States Of America). Gender differences in plasma biomarkers levels in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 1800

Member's Comments

No comment yet.

Related content which might interest you: Gender related differences of circulating leptin in COPD Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation Year: 2009 Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Gender differences of predictors of health status in patients with COPD Source: Annual Congress 2011 - COPD management Year: 2011 Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 Gender differences in hospitalised COPD patients Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 The relationship of plasma adropin levels in pediatric obese patients with OSA Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019 Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients Source: International Congress 2016 – Latest insights into chronic care Year: 2016 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 LATE-BREAKING ABSTRACT: Circulating YKL-40 level in COPD patients and their correlations with clinical parameters Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Characterisation of asthma subgroups associated with circulating YKL-40 levels Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017 Year: 2017 Leptin levels in induced sputum from patients with COPD are sensitive to smoking status Source: Eur Respir J 2005; 26: Suppl. 49, 660s Year: 2005 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013